Schrodinger

Overview

Schrodinger is a computational platform company headquartered in New York at 1540 Broadway, 24th Floor[1]. Founded in 1990[4], the company provides physics-based software solutions for drug discovery and materials science[2][3]. Its life science offerings include Maestro, Glide, FEP+, LiveDesign and BioLuminate, while its materials science suite comprises MS Maestro, MS Desmond, MS Jaguar and MS LiveDesign[6]. The company serves customers across aerospace, automotive, biotech, pharmaceuticals, consumer packaged goods, oil and gas, semiconductors and specialty chemicals[3]. Schrodinger operates its own clinical programs, including SGR-1505, a MALT1 inhibitor, and SGR-3515, a Wee1/Myt1 inhibitor[7]. With approximately 900 employees across 12 global offices[5], the company states its mission as transforming the discovery of therapeutics and materials, citing over 30 years of continuous research and development investment[10].

Headquarters listed as New York: 1540 Broadway, 24th Floor, New York, NY 10036 [2]

Schrodinger states it was founded in 1990. [4]

Schrodinger's life science software includes Maestro, Glide, FEP+, LiveDesign and BioLuminate, and its materials science suite includes MS Maestro, MS Desmond, MS Jaguar and MS LiveDesign. [6]

Schrodinger runs its own clinical programs including SGR-1505, a MALT1 inhibitor, and SGR-3515, a Wee1/Myt1 inhibitor. [7]

Growth & traction

Schrodinger says it has approximately 900 employees across 12 offices globally. [5]

Customers

Schrodinger names Morphic Therapeutic as a customer example on its homepage. [8]